本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Travere Therapeutics, Inc.

66.17
-1.3400-1.98%
盤後66.170.00000.00%19:30 EDT
成交量:114.98萬
成交額:7,694.43萬
市值:62.37億
市盈率:-138.88
高:68.73
開:67.76
低:66.11
收:67.51
52周最高:68.73
52周最低:22.06
股本:9,426.11萬
流通股本:9,276.71萬
量比:0.91
換手率:1.24%
股息:- -
股息率:- -
每股收益(TTM):-0.4764
每股收益(LYR):-0.2864
淨資產收益率:-236.35%
總資產收益率:-3.73%
市淨率:254.35
市盈率(LYR):-231.08

資料載入中...

2025/12/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/30

重要事件披露

Form 8-K - Current report
2025/10/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/10

重要事件披露

Form 8-K - Current report
2025/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/06

重要事件披露

Form 8-K - Current report
2025/06/17

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/05/16

重要事件披露

Form 8-K - Current report
2025/05/15

重要事件披露

Form 8-K - Current report
2025/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities